Snyder JP - Search Results

1

Visualizing cancer and response to therapy in vivo using Cy5.5-labeled factor VIIa and anti-tissue factor antibody.

Zhu S, Kisiel W, Lu YJ, Petersen LC, Ndungu JM, Moore TW, Parker ET, Sun A, Sarkaria JN, Snyder JP, Liotta DC, Brat DJ, El-Rayes BF, Shoji M. Zhu S, et al. Among authors: snyder jp. J Drug Target. 2015 Apr;23(3):257-65. doi: 10.3109/1061186X.2014.988217. Epub 2014 Dec 16. J Drug Target. 2015. PMID: 25510254 Free PMC article.

2

Synthesis of EF24-tripeptide chloromethyl ketone: a novel curcumin-related anticancer drug delivery system.

Sun A, Shoji M, Lu YJ, Liotta DC, Snyder JP. Sun A, et al. Among authors: snyder jp. J Med Chem. 2006 Jun 1;49(11):3153-8. doi: 10.1021/jm051141k. J Med Chem. 2006. PMID: 16722634

3

Targeting tissue factor-expressing tumor angiogenesis and tumors with EF24 conjugated to factor VIIa.

Shoji M, Sun A, Kisiel W, Lu YJ, Shim H, McCarey BE, Nichols C, Parker ET, Pohl J, Mosley CA, Alizadeh AR, Liotta DC, Snyder JP. Shoji M, et al. Among authors: snyder jp. J Drug Target. 2008 Apr;16(3):185-97. doi: 10.1080/10611860801890093. J Drug Target. 2008. PMID: 18365880

4

Targeted delivery of paclitaxel to tumor cells: synthesis and in vitro evaluation.

Ndungu JM, Lu YJ, Zhu S, Yang C, Wang X, Chen G, Shin DM, Snyder JP, Shoji M, Sun A. Ndungu JM, et al. Among authors: snyder jp. J Med Chem. 2010 Apr 22;53(8):3127-32. doi: 10.1021/jm901763f. J Med Chem. 2010. PMID: 20302303 Free PMC article.

5

Tumor angiogenesis therapy using targeted delivery of Paclitaxel to the vasculature of breast cancer metastases.

Zhu S, Kisiel W, Lu YJ, Petersen LC, Ndungu JM, Moore TW, Parker ET, Sun A, Liotta DC, El-Rayes BF, Brat DJ, Snyder JP, Shoji M. Zhu S, et al. Among authors: snyder jp. J Drug Deliv. 2014;2014:865732. doi: 10.1155/2014/865732. Epub 2014 Dec 7. J Drug Deliv. 2014. PMID: 25574399 Free PMC article.

6

Highly active anticancer curcumin analogues.

Mosley CA, Liotta DC, Snyder JP. Mosley CA, et al. Among authors: snyder jp. Adv Exp Med Biol. 2007;595:77-103. doi: 10.1007/978-0-387-46401-5_2. Adv Exp Med Biol. 2007. PMID: 17569206 Review.

7

Synthetic curcumin analog EF31 inhibits the growth of head and neck squamous cell carcinoma xenografts.

Zhu S, Moore TW, Lin X, Morii N, Mancini A, Howard RB, Culver D, Arrendale RF, Reddy P, Evers TJ, Zhang H, Sica G, Chen ZG, Sun A, Fu H, Khuri FR, Shin DM, Snyder JP, Shoji M. Zhu S, et al. Among authors: snyder jp. Integr Biol (Camb). 2012 Jun;4(6):633-40. doi: 10.1039/c2ib20007d. Epub 2012 Apr 25. Integr Biol (Camb). 2012. PMID: 22532032 Free PMC article.

8

Synthetic curcumin analog UBS109 inhibits the growth of head and neck squamous cell carcinoma xenografts.

Zhu S, Moore TW, Morii N, Howard RB, Culver D, Arrendale RF, Reddy P, Evers TJ, Zhang H, Sica G, Chen ZG, Sun A, Fu H, Khuri FR, Shin DM, Snyder JP, Shoji M. Zhu S, et al. Among authors: snyder jp. Curr Cancer Drug Targets. 2014;14(4):380-93. doi: 10.2174/1568009614666140312163524. Curr Cancer Drug Targets. 2014. PMID: 24628271

9

Liver S9 Fraction-Derived Metabolites of Curcumin Analogue UBS109.

Moore TW, Zhu S, Randolph R, Shoji M, Snyder JP. Moore TW, et al. Among authors: snyder jp. ACS Med Chem Lett. 2014 Jan 10;5(4):288-92. doi: 10.1021/ml4002453. eCollection 2014 Apr 10. ACS Med Chem Lett. 2014. PMID: 24900828 Free PMC article.

10

Antiangiogenic effects of a novel synthetic curcumin analogue in pancreatic cancer.

Nagaraju GP, Zhu S, Ko JE, Ashritha N, Kandimalla R, Snyder JP, Shoji M, El-Rayes BF. Nagaraju GP, et al. Among authors: snyder jp. Cancer Lett. 2015 Feb 28;357(2):557-65. doi: 10.1016/j.canlet.2014.12.007. Epub 2014 Dec 9. Cancer Lett. 2015. PMID: 25497868

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

190 results

Search Page